Dilon Diagnostics Partners with Digirad to Distribute Nuclear Imaging Systems

Digirad Corp. (Suwanee, GA, USA), a developer of in solid-state diagnostic imaging technology and services, and Dilon Diagnostics (Newport News, VA,USA), a developer of molecular breast imaging, have signed an exclusive international distribution agreement for Dilon to distribute Digirad’s range of nuclear imaging cameras, which include the ergo, a large field-of-view general purpose imaging system, the Cardius x.act, a triple-head cardiac single photon emission computed tomography (SPECT) imaging system with high-resolution volume CT (VCT) attenuation correction, and the Cardius XPO cardiac SPECT imaging systems line.

The agreement includes distribution of Digirad systems to most countries outside the United States. The signing of this agreement continues the relationship that Digirad and Dilon have been building since the two companies signed a technology development agreement in mid-2010. Digirad president and CEO Matthew G. Molchan, said, “We are very pleased with this enhanced relationship with Dilon and the opportunity to further expand our product reach beyond the United States. We continue to believe that our nuclear imaging cameras, with their solid-state design and technology, are well suited to meet the needs of the international market and we are very excited to partner with Dilon to distribute our cameras around the world. We believe our products will be an excellent complement to the already extensive Dilon product line-up.”

Dilon Diagnostics chairman and CEO Robert G. Moussa, said, “We are extremely pleased to expand our already successful partnership with Digirad and are excited to broaden our offering of nuclear imaging products in the international marketplace. With the addition of the Digirad cameras to the existing Dilon product portfolio, we now have the ability to offer a full spectrum of diagnostic imaging solutions to our international customers and to afford the excellent range of Digirad's nuclear imaging products access to our broad international network of customers.”

Dilon Diagnostics, a brand of Dilon Technologies, Inc., and the company’s key product, the Dilon 6800, is a high-resolution, small field-of-view digital gamma camera, optimized for molecular breast imaging, also known as breast-specific gamma imaging (MBI/BSGI). MBI utilizes radiotracer uptake to detect the increased metabolic activity of breast lesions and therefore, is not affected by breast density. Both the Dilon 6800 and Acella systems provide high photon sensitivity; and Dilon’s GammaLoc system is the only localization device on the market to enable molecular-guided breast biopsy.

Digirad is one of the largest US providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers, and also markets medical diagnostic imaging systems for nuclear cardiology and general nuclear medicine applications.

Related Links:
Digirad
Dilon Diagnostics